Comprehensive Guide to Split-Thickness Skin Graft (STSG)

1. Introduction and Overview

A Split-Thickness Skin Graft (STSG) is a fundamental reconstructive surgical procedure used to replace lost or damaged skin. It involves the harvesting of the epidermis and a portion of the dermis from a healthy donor site and transferring it to a recipient site (the wound bed). Unlike Full-Thickness Skin Grafts (FTSG), which include the entire dermis, an STSG preserves a portion of the dermis at the donor site, allowing the donor area to re-epithelialize spontaneously.

This procedure remains the gold standard for closing large surface area wounds where primary closure is impossible or contraindicated. It is a cornerstone of burn surgery, trauma reconstruction, and the management of chronic, non-healing ulcers.

2. Technical Specifications and Mechanisms

The physiology of an STSG relies on the process of "take," which is the integration of the graft into the recipient bed. The mechanism occurs in three distinct phases:

Graft Thickness Classifications

• Thin STSG (0.005–0.012 inches): Higher success rate due to easier revascularization but prone to contraction and poor aesthetic outcomes.
• Medium STSG (0.012–0.018 inches): The clinical balance between survival and long-term durability.
• Thick STSG (0.018–0.024 inches): More durable and aesthetically superior, but requires a highly vascularized wound bed for successful "take."

3. Extensive Clinical Indications and Usage

STSG is indicated when the wound bed has sufficient vascularity to support graft survival. Common clinical scenarios include:

• Thermal and Chemical Burns: Particularly deep partial-thickness or full-thickness burns.
• Traumatic Skin Loss: Extensive avulsion injuries or degloving injuries where the skin cannot be salvaged.
• Chronic Wounds: Debridement and coverage of recalcitrant venous stasis ulcers or pressure sores.
• Oncological Reconstruction: Post-excision defects where primary closure would cause functional impairment (e.g., joint restriction).
• Infected Wounds (Post-Debridement): Once the wound bed is deemed "granulation-healthy" and bacterial counts are below threshold (typically <10^5 organisms per gram of tissue).

4. Patient Pre-Operative Preparation

Success starts well before the scalpel touches the patient.

1. Nutritional Optimization: Assessment of serum albumin and pre-albumin levels. Patients must be in an anabolic state for wound healing.
2. Wound Bed Preparation: The recipient site must be free of necrotic tissue, eschar, and active infection. Serial debridement or Negative Pressure Wound Therapy (NPWT) is often used to optimize the bed.
3. Vascular Assessment: In lower extremity cases, Doppler studies or ABI (Ankle-Brachial Index) testing are mandatory to ensure adequate perfusion.
4. Informed Consent: Must include discussion of donor site pain, scarring, and the possibility of graft failure.

5. The Procedure: Step-by-Step

A. Donor Site Harvesting

1. Selection: Common sites include the thigh, buttocks, or back. The site must be flat and easily accessible.
2. Preparation: The site is lubricated with sterile mineral oil or saline to allow the dermatome to glide smoothly.
3. Harvesting: Using a calibrated dermatome, the surgeon removes the required thickness of skin.
4. Hemostasis: The donor site is dressed with topical thrombin, epinephrine-soaked gauze, or an occlusive dressing (e.g., hydrocolloid or silver-impregnated dressings).

B. Recipient Site Preparation

1. Debridement: The wound bed is surgically debrided to bleeding, healthy tissue.
2. Hemostasis: Precise control of bleeding is required to prevent hematoma formation, which is the #1 cause of graft failure.
3. Meshing: The graft is often passed through a "mesher" (usually 1.5:1 or 3:1 ratio). Meshing allows for fluid drainage, prevents hematoma, and increases the surface area coverage of the graft.

C. Fixation and Dressing

1. Placement: The graft is secured using staples, sutures, or fibrin glue.
2. Bolster Dressing: A "tie-over" bolster or NPWT is applied to ensure intimate contact between the graft and the bed, preventing shear forces.

6. Post-Operative Recovery Protocol

• Immobilization: The grafted area must be immobilized for 5–7 days to allow for vascular ingrowth.
• NPWT Management: If a vacuum dressing is used, it is typically maintained for 3–5 days at 75–125 mmHg.
• Elevation: To minimize edema, which can lift the graft from the wound bed.
• Monitoring: The graft is inspected for "take" (pink/healthy) vs. "failure" (dark, necrotic, or fluid-filled).
• Long-term: Once the graft is healed, patients are encouraged to use silicone sheets or compression garments for 6–12 months to manage hypertrophic scarring.

7. Risks, Side Effects, and Contraindications

Complications

• Hematoma/Seroma: Fluid accumulation beneath the graft is the most common cause of failure.
• Infection: Beta-hemolytic streptococcus is a notorious graft-destroyer.
• Graft Failure: Total or partial loss due to poor vascularity or shear.
• Hypertrophic Scarring: Common at both the recipient and donor sites.
• Contracture: STSGs have a tendency to shrink over time, which can lead to functional limitations over joints.

Contraindications

• Active Infection: High bacterial load at the recipient site.
• Poor Vascularity: Untreated arterial insufficiency.
• Patient Non-Compliance: Inability to maintain strict immobilization.
• Uncontrolled Diabetes: Severe hyperglycemia significantly impairs angiogenesis.

8. Alternative Treatments

• Full-Thickness Skin Grafts (FTSG): Better aesthetics and less contraction but limited to smaller, clean, well-vascularized wounds.
• Local or Free Flaps: Required when bone, tendon, or cartilage is exposed (as STSGs will not take on bare bone).
• Dermal Substitutes: Bioengineered matrices (e.g., Integra) used to build a "neodermis" before applying a thin STSG.
• Secondary Intention: Allowing the wound to close on its own; usually reserved for small, low-tension wounds.

9. Massive FAQ Section

Q1: How long does an STSG take to heal?
A: The graft typically adheres by day 5, but the donor site usually epithelialize within 10–14 days. Full maturation of the graft takes 6–12 months.

Q2: Will the graft grow with the patient?
A: No. Unlike FTSG or flaps, STSGs do not have the same growth potential and may require revision if placed on a pediatric patient.

Q3: What is the purpose of "meshing" the skin?
A: Meshing allows blood and fluid to escape through the holes, preventing hematomas, and it allows the graft to cover a larger area of the wound.

Q4: Why does the donor site hurt more than the graft site?
A: The donor site is essentially a large partial-thickness burn. It exposes nerve endings and remains an open wound, making it painful until re-epithelialization is complete.

Q5: Can I shower after the surgery?
A: Not until the surgeon gives clearance, usually after the first dressing change (3–5 days post-op).

Q6: What happens if the graft turns black?
A: A black graft may indicate necrosis (death of the tissue). You must contact your surgeon immediately for evaluation.

Q7: Can STSGs be used on the face?
A: They can, but FTSGs are usually preferred for the face due to better color match and less contraction.

Q8: What is the difference between a "tie-over" bolster and NPWT?
A: Both provide pressure. NPWT (vacuum) is generally superior as it actively removes exudate and promotes angiogenesis, whereas a tie-over bolster is a static dressing.

Q9: Will I have permanent scarring?
A: Yes. Both the harvest site and the graft site will result in permanent changes to skin texture and pigmentation.

Q10: Are there dietary recommendations for recovery?
A: Yes. High-protein intake, Vitamin C, and Zinc supplementation are often recommended to support collagen synthesis and epithelial cell migration.

10. Summary Table for Clinical Decision Making

Disclaimer: This guide is intended for educational purposes for healthcare professionals and students. It does not replace institutional protocols or individual clinical judgment. Always consult with a board-certified plastic or orthopedic surgeon for specific patient management.